Unloxcyt

Cosibelimab · Sun Pharmaceutical Industries, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)

Unloxcyt ingredients

Active ingredientStrength
Cosibelimab300 mg/5mL

What Unloxcyt is used for

Unloxcyt is a cancer medicine (programmed death ligand-1 blocker). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Unloxcyt
Generic name
Cosibelimab
Made by
Sun Pharmaceutical Industries, Inc.
Forms
Injection, Solution
Given
Intravenous
Drug class
Programmed Death Ligand-1 Blocker
FDA approval
Biologic licence (BLA) BLA761297
On the US market since
2025

Official information

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Unloxcyt?

Unloxcyt (Cosibelimab) is a cancer medicine made by Sun Pharmaceutical Industries, Inc., approved by the US FDA.

What are the ingredients of Unloxcyt?

Unloxcyt contains Cosibelimab (300 mg/5mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.